TrialJournal of immunology research2016

Randomized Phase II Study of Docetaxel plus Personalized Peptide Vaccination versus Docetaxel plus Placebo for Patients with Previously Treated Advanced Wild Type EGFR Non-Small-Cell Lung Cancer.

Koichi Takayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.